EyePoint Pharmaceuticals, Inc. (36) | Business Operations (5)
Browse by Subcategory
Recent Contracts
-
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
(Filed With SEC on March 14, 2022)
-
Controlled Equity OfferingSM Sales Agreement, dated August 5, 2020, by and between EyePoint Pharmaceuticals, Inc. and Cantor Fitzgerald & Co
(Filed With SEC on August 5, 2020)
-
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
(Filed With SEC on March 12, 2021)
-
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors
(Filed With SEC on August 7, 2019)
-
At Market Issuance Sales Agreement, dated January 18, 2019, between EyePoint Pharmaceuticals, Inc. and B. Riley FBR, Inc
(Filed With SEC on January 18, 2019)